瑞信：维持启明医疗-B“跑赢大市” 评级 目标价 100 港元

Zhitong
2021.07.05 02:04
智通财经 APP 获悉，瑞信发布研究报告，维持启明医疗-B(02500)“跑赢大市” 评级，目标价 100 港元，公司今年首 5 个月已完成 1500 个经导管主动脉瓣置换术 (TAVR) 相关手术，预计上半年手术量可达到 1900 个。
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.